医薬品リファレンス
Erenumab
Erenumab is a medicine in the class central nervous system. It is used for migraine.
- 薬効分類: Central Nervous System
- 効能・効果: migraine
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
要点
- 薬効分類
- Central Nervous System
- ATCコード
- N02CD01
- 一般的な剤形
- 注射剤
- 一般的な規格
- 70 mg/ml, 140 mg/ml
- 商品名
- 5
- 国・市場
- 5
何に使われるか
作用のしくみ
Human monoclonal antibody; binds to the calcitonin gene-related peptide (CGRP) receptor, which is thought to be causally involved in migraine pathophysiology
成人の通常用量（添付文書の要約）
70 mg SC once monthly
妊娠と授乳
- 妊娠
- Unknown Limited human data; no harm to offspring in monkeys. As an IgG antibody it crosses the placenta, mainly late in pregnancy. A pregnancy registry exists. EU label: as a precaution, preferable to avoid in pregnancy.
- 授乳
- Unknown No milk data. EU label: a risk cannot be excluded in the first days after birth; afterwards use only if clinically needed. LactMed: likely low in milk; two infants had no effects. Use with caution with a newborn.
報告されている副作用
- Injection site pain.
- Constipation.
- Cramps, muscle spasms
- Immune system disorders: Rash, angioedema, anaphylaxis
注意が必要な方
- Development of hypertension and worsening of pre-existing hypertension reported
- Constipation with serious complications reported in the postmarketing setting; cases that required hospitalization, including cases where surgery was necessary reported
妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Erenumabの完全なモノグラフ（用量、妊娠・授乳、副作用、警告、すべての相互作用）を表示できます。
- Dosing by age, kidney and liver function, and further dose lines
- Paediatric dosing
- Patient counselling points
- Food interactions
WebでPro+を14日間無料でお試し。カード登録不要。
同じ分類のほかの薬剤
よくある質問
What is Erenumab used for?
Erenumab is a medicine in the class central nervous system. It is used for Migraine.
What side effects have been reported with Erenumab?
Injection site pain., Constipation., Cramps, muscle spasms, Immune system disorders: Rash, angioedema, anaphylaxis.
Can Erenumab be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Limited human data; no harm to offspring in monkeys. As an IgG antibody it crosses the placenta, mainly late in pregnancy. A pregnancy registry exists. EU label: as a precaution, preferable to avoid in pregnancy. Breastfeeding: Unknown. No milk data. EU label: a risk cannot be excluded in the first days after birth; afterwards use only if clinically needed. LactMed: likely low in milk; two infants had no effects. Use with caution with a newborn.
What does Erenumab interact with?
MediHelp does not list a checked interaction for Erenumab yet. Always tell your pharmacist about every medicine you take.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
